Marten Schulz Selected Research

Marten Schulz Research Topics

4	Fibrosis (Cirrhosis) 07/2022 - 01/2020
3	Chronic Hepatitis (Chronic Active Hepatitis) 07/2022 - 01/2019
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 12/2016
2	Infections 01/2020 - 01/2019
1	Lymphoma (Lymphomas) 07/2022
1	Inflammation (Inflammations) 10/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 05/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Liver Diseases (Liver Disease) 12/2016
1	Chronic Hepatitis B 09/2014
1	Superinfection 09/2014

2	Ribavirin (Virazole)FDA LinkGeneric 07/2022 - 01/2019
1	Antiviral Agents (Antivirals)IBA 07/2022
1	InflammasomesIBA 10/2021
1	Bile Acids and Salts (Bile Acids)IBA 10/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021
1	Epoxide HydrolasesIBA 01/2021
1	LipidsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Rituximab (Mabthera)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	SofosbuvirIBA 01/2019
1	AntibodiesIBA 12/2016
1	Immunoglobulin G (IgG)IBA 12/2016
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2014

4	Therapeutics 07/2022 - 01/2019
1	Kidney Transplantation 07/2022
1	Hematopoietic Stem Cell Transplantation 05/2021
1	Organ Transplantation 01/2020